Association between Coronary Artery Disease and Left Ventricle Remodeling Parameters in Hypertensive Patients: A Cross-Sectional Study in a Limited Resource Setting
DOI:
https://doi.org/10.3889/oamjms.2021.7293Keywords:
Coronary artery disease, Hypertension, Left ventricle concentricity, Left ventricle hypertrophy, Left ventricle dilatation, Left ventricle remodelingAbstract
BACKGROUND: Coronary artery disease (CAD) and hypertension are related with left ventricle (LV) remodeling, however evidence about association between CAD and remodeling in hypertensive patient is still limited, especially in limited resource setting like Indonesia.
AIM: Evaluating impact of CAD on LV remodeling within hypertensive patients at tertiary referral hospital, Hasan Sadikin General Hospital Bandung, Indonesia.
METHOD: Cross-sectional study involving 120 hypertensive patients who visited cardiology outpatient clinic from September-December 2019 and underwent transthoracic echocardiography examination for any medical indications. LV remodeling parameters, such as mass (LV Mass Index [LVMi]), volume (end-diastolic volume/body surface area [BSA]), and relative wall thickness (RWT), were compared between CAD and non-CAD groups.
RESULTS: There were 108 patients to be analyzed, 12 patients were excluded due to technical difficulty (n = 9) and non-cooperative during interview (n = 3). Mean (standard deviation) age of patients was 56.9 (±11.8) years, 50 (46.3%) patients were male, and median (interquartile range) hypertension duration was 3 (±4.40) years. CAD was found in 40 (37.0%) patients. In the adjusted analysis, patients with CAD had average 27.75 g/m2 higher LVMi (95% confined interval [CI] 2.03; 53.47; p = 0.035) and 16.20 ml/m2 higher LV end-diastolic volume/BSA (95% CI 4.14; 28.25; p = 0.009) compared to those without. This was independent of age, duration of hypertension, consumption of antihypertensive therapy, and type-2 diabetes mellitus, but disappeared after heart failure (HF) was included in the study. CAD and non-CAD groups were not different, respectively, to RWT.
CONCLUSION: In hypertensive patients, CAD was independently associated with higher LV mass and volume. These associations, however, were largely explained by the presence of HF. CAD did not associate with RWT.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: Current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108. https://doi.org/10.1016/j.jcmg.2010.10.008 PMid:21232712 DOI: https://doi.org/10.1016/j.jcmg.2010.10.008
Anand IS, Florea VG, Solomon SD, Konstam MA, Udelson JE. Noninvasive assessment of left ventricular remodeling: Concepts, techniques, and implications for clinical trials. J Card Fail. 2002;8(Suppl):S452-64. https://doi.org/10.1054/jcaf.2002.129286 PMid:12555158 DOI: https://doi.org/10.1054/jcaf.2002.129286
Azevedo PS, Polegato BF, Minicucci MF, Paiva SAR, Zornoff LAM. Cardiac remodeling: Concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106(1):62-9. https://doi.org/10.5935/abc.20160005 PMid:26647721 DOI: https://doi.org/10.5935/abc.20160005
Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32(5):1454-9. https://doi.org/10.1016/s0735-1097(98)00407-0 PMid:9809962 DOI: https://doi.org/10.1016/S0735-1097(98)00407-0
Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: The VALIANT (VALsartan In Acute myocardial iNfarcTion) echocardiographic study. JACC Cardiovasc Imaging. 2008;1(5):582-91. https://doi.org/10.1016/j.jcmg.2008.05.012 PMid:19356485 DOI: https://doi.org/10.1016/j.jcmg.2008.05.012
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322(22):1561-6. https://doi.org/10.1056/nejm199005313222203 PMid:2139921 DOI: https://doi.org/10.1056/NEJM199005313222203
Restini CB, Garcia AF, Natalin HM, Natalin GM, Rizzi E. Signaling Pathways of Cardiac Remodeling Related to Angiotensin II. Renin-Angiotensin System - Past, Present and Future; 2017. https://doi.org/10.5772/66076 DOI: https://doi.org/10.5772/66076
Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, et al. Cardiovascular remodeling in coronary artery disease and heart failure. Lancet 2014;383(9932):1933-43. https://doi.org/10.1016/s0140-6736(14)60107-0 PMid:24831770 DOI: https://doi.org/10.1016/S0140-6736(14)60107-0
Uçar H, Gür M, Börekçi A, Yıldırım A, Baykan AO, Kalkan GY, et al. Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. Anatol J Cardiol. 2015;15(10):789-94. https://doi.org/10.5152/akd.2014.5747 PMid:25592099 DOI: https://doi.org/10.5152/akd.2014.5747
Fernandes-Silva MM, Shah AM, Hedge S, Goncalves A, Claggett B, Cheng S, et al. Race-related differences in left ventricular structural and functional remodeling in response to increased afterload: The atherosclerosis risk in communities study. JACC Heart Fail. 2017;5(3):157-65. https://doi.org/10.1016/j.jchf.2016.10.011 Mid:28017356 DOI: https://doi.org/10.1016/j.jchf.2016.10.011
Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the use of echocardiography in adult hypertension: A report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16(6):577-605. https://doi.org/10.1016/j.echo.2015.05.002 PMid:25995329 DOI: https://doi.org/10.1016/j.echo.2015.05.002
Zabalgoitia M, Berning J, Koren MJ, Støylen A, Nieminen MS, Dahlöf B, et al. Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2001;88(6):646-50. https://doi.org/10.1016/s0002-9149(01)01807-0 PMid:11564388 DOI: https://doi.org/10.1016/S0002-9149(01)01807-0
Kishi S, Magalhaes TA, George RT, Dewey M, Laham RJ, Niinuma H, et al. Relationship of left ventricular mass to coronary atherosclerosis and myocardial ischaemia: The CORE320 multicenter study. Eur Heart J Cardiovasc Imaging. 2015;16(2):166-76. https://doi.org/10.1093/ehjci/jeu217 PMid:25368207 DOI: https://doi.org/10.1093/ehjci/jeu217
Drazner MH. The progression of hypertensive heart disease. Circulation. 2011;123(3):327-34. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.845792
Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104(13):1477-82. https://doi.org/10.1161/hc3801.096325 PMid:11571239 DOI: https://doi.org/10.1161/hc3801.096325
Pierdomenico SD. Left-ventricular hypertrophy and coronary artery disease. Am J Hypertens. 2007;20(10):1036-7. https://doi.org/10.1016/j.amjhyper.2007.06.002 PMid:17903684 PMid:21232712 DOI: https://doi.org/10.1016/j.amjhyper.2007.06.002
Maiello M, Zito A, Carbonara S, Ciccone MM, Palmiero P. Left ventricular mass, geometry and function in diabetic patients affected by coronary artery disease. J Diabetes Complications. 2017;31(10):1533-7. https://doi.org/10.1016/j.jdiacomp.2017.06.014 PMid:28890308 DOI: https://doi.org/10.1016/j.jdiacomp.2017.06.014
Lala A, Desai AS. The role of coronary artery disease in heart failure. Heart Fail Clin. 2014;10(2):353-65. https://doi.org/10.1016/j.hfc.2013.10.002 PMid:24656111 DOI: https://doi.org/10.1016/j.hfc.2013.10.002
Hajouli S, Ludhwani D. Heart Failure And Ejection Fraction. Treasure Island, FL: StatPearls Publishing; 2021.
Aimo A, Gaggin HK, Barison A, Emdin M, Januzzi JL. Imaging, biomarker, and clinicalpredictors of cardiac remodelingin heart failure with reduced ejection fraction. JACC Heart Fail. 2019;7(9):782-94. https://doi.org/10.1016/j.jchf.2019.06.004 PMid:31401101 DOI: https://doi.org/10.1016/j.jchf.2019.06.004
Seko Y, Kato T, Morita Y, Yamaji Y, Haruna Y, Izumi T, et al. Impact of left ventricular concentricity on long-term mortality in a hospital-based population in Japan. PLoS One. 2018;13(8):e0203227. https://doi.org/10.1371/journal.pone.0203227 PMid:30161243 DOI: https://doi.org/10.1371/journal.pone.0203227
Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, et al. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging. 2014;7(3):422-9. https://doi.org/10.1161/CIRCIMAGING.113.001275 PMid:24723582 PMid:24831770 DOI: https://doi.org/10.1161/CIRCIMAGING.113.001275
Cokkinos DV, Belogianneas C. Left ventricular remodeling: A problem in search of solutions. Eur Cardiol. 2016;11(1):29-35. https://doi.org/10.15420/ecr.2015:9:3 PMid:30310445 DOI: https://doi.org/10.15420/ecr.2015:9:3
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Badai Tiksnadi, Erwan Martanto, Abednego Panggabean, Ary Indriana Savitri, Alberta Claudia Undarsa (Author)
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
Funding data
-
Erasmus+
Grant numbers 585898-EPP-1-2017-1-NL-EPPKA2-CBHE-JP